Product image unavailable

Neostigmine

Vendor: Marketplace supplier

Formulations: - Parenteral > General injections > unspecified: 0.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate) Oral > Solid > tablet: 15 mg (neostigmine bromide) Indications: - Myasthenia gravis - Anticholinesterase reversible Source: EML workbook import

Product metadata will be available once the catalog entry is complete.

Kes0.00

VariantSupplierQuantity

Availability

Supplier and price will be confirmed during RFQ.

View Cart

Similar Products

Pyridostigmine

Formulations: - Parenteral > General injections > IV: 5 mg per mL in ampoule or vial (pyridostigmine bromide) Oral > Solid > tablet: 60 mg scored (pyridostigmine bromide) Indications: - Myasthenia gravis Source: EML workbook import

MOQ: 1

Kes0.00